REGN vs USB · P/E 14, rev $14.34B vs P/E 12, rev $28.66B
Regeneron Pharmaceuticals Inc (REGN) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the REGN and USB stock pages for the full models.
Not investment advice.